tiprankstipranks
Trending News
More News >
AdAlta Ltd. (AU:1AD)
ASX:1AD
Australian Market
Advertisement

AdAlta Ltd. (1AD) Price & Analysis

Compare
4 Followers

1AD Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

2.06%97.94%
Mutual Funds
― Other Institutional Investors
97.94% Public Companies and
Individual Investors

1AD FAQ

What was AdAlta Ltd.’s price range in the past 12 months?
AdAlta Ltd. lowest share price was AU$0.01 and its highest was AU$0.03 in the past 12 months.
    What is AdAlta Ltd.’s market cap?
    AdAlta Ltd.’s market cap is AU$2.23M.
      When is AdAlta Ltd.’s upcoming earnings report date?
      AdAlta Ltd.’s upcoming earnings report date is Aug 22, 2025 which is in 26 days.
        How were AdAlta Ltd.’s earnings last quarter?
        AdAlta Ltd. released its earnings results on Feb 20, 2025. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
          Is AdAlta Ltd. overvalued?
          According to Wall Street analysts AdAlta Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does AdAlta Ltd. pay dividends?
            AdAlta Ltd. does not currently pay dividends.
            What is AdAlta Ltd.’s EPS estimate?
            AdAlta Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does AdAlta Ltd. have?
            AdAlta Ltd. has 1,112,983,200 shares outstanding.
              What happened to AdAlta Ltd.’s price movement after its last earnings report?
              AdAlta Ltd. reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of AdAlta Ltd.?
                Currently, no hedge funds are holding shares in AU:1AD

                AdAlta Ltd. Stock Smart Score

                Company Description

                AdAlta Ltd.

                AdAlta Ltd. (1AD) is a biotechnology company specializing in the research and development of next-generation protein therapeutics, known as i-bodies. These i-bodies are engineered to mimic the properties of antibodies and are designed to address challenging medical conditions that are not adequately treated by current therapies. The company operates primarily within the healthcare and biotechnology sectors, focusing on innovative solutions for the treatment of fibrotic diseases and cancer.
                Similar Stocks
                Company
                Price & Change
                Follow
                Vectus Biosystems Limited
                Anatara Lifesciences Ltd
                Bio-Gene Technology Ltd.
                Hexima Ltd
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis